BDNF and depressive symptom measurement: This compound mimics the processes taking place in the development of depression, i.e., by inhibiting protein glycosylation, resulting in accumulation of misfolded proteins in astrocytes and decreasing the release of BDNF in astrocytes (Figure 4 and Figure 7; Table S1).